Companies / Malaysia
Ranbaxy Targets Statins Market
September 2006 | Product LaunchIndian drugmaker Ranbaxy has announced that its' Malaysian subsidiary has launched a generic version of Atorvastatin under the brand name Storvas. The product will be made available though all general practitioners, pharmacies and hospitals in the
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
